Significance of autoantibodies to oxidatively modified LDL in plasma of children with down syndrome [5]

Clinical Chemistry

Volumn 47, Issue 6 I, 2001, Pages 1135-1137

  Fulgenzi, A ^a   Wasserman, K ^a   Corsi, M M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; ALDEHYDE; AUTOANTIBODY; CELL ADHESION MOLECULE; CHOLESTEROL; CHROMOGENIC SUBSTRATE; EPITOPE; GROWTH FACTOR; IMMUNOGLOBULIN G; LIPID PEROXIDE; LYSINE; MALONALDEHYDE; N METHYL 2 PHENYLINDOLE; OXIDIZED LOW DENSITY LIPOPROTEIN; OXYGEN; THROMBOPLASTIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CELL PROLIFERATION; CHILD; CHOLESTEROL BLOOD LEVEL; CHROMOSOME 21; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DOWN SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOAM CELL; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; LETTER; LIPID OXIDATION; LYMPHOCYTE MIGRATION; MACROPHAGE; MALE; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; RISK FACTOR; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR SMOOTH MUSCLE;

EID: 0035021832     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.6.1135     Document Type: Letter

References (21)

1. Role of oxidatively modified LDL in atherosclerosis
2. Free radical modification of lipoproteins and cholesterol accumulation in cells upon atherosclerosis
3. Low density lipoprotein undergoes oxidative modification in vivo
4. Modified forms of low-density lipoprotein and atherosclerosis
5. Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein
6. Baseline diene conjugation in LDL lipids: An indicator of circulating oxidized LDL
7. Oxidants and antioxidants in the pathogenesis of atherosclerosis: Implications for the oxidized low density lipoprotein hypothesis
8. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits
9. Cholesterol fractions and triglycerides in children and adults with Down's syndrome
10. Down's syndrome: An atheroma-free model?
11. Metabolic studies in mongolism: Serum protein-bound iodine, cholesterol, and lipoprotein
12. Plasma lipids and lipoproteins in Down's syndrome
13. Hyperlipidaemia in patients with Down's syndrome
14. Determination of aldehydic lipid peroxidation products: Malondialdehyde and 4-hydroxynonenal
15. Autoantibodies against oxidized low density lipoprotein: A review of clinical findings and assay methodology
16. The oxidation hypothesis of atherosclerosis
17. Mildly oxidized low-density lipoproteins suppress the proliferation of activated CD4+ T lymphocytes and their interleukin-2 receptor expression in vitro
18. Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies
19. Relationship between serum concentrations of autoantibodies against oxidized low density lipoprotein, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease
20. Identification and characterization of a new human cDNA from chromosome 21q22.3 encoding a basic nuclear protein
21. Developmental expression of the SH3BGR gene, mapping to the Down syndrome heart critical region